serdexmethylphenidate and dexmethylphenidate

FDA approved for the treatment of Attention Deficit Hyperactivity.

Also Known As:

azstarys

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/01/2023 - "Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD." 10/04/2021 - "Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD."

1.	Dexmethylphenidate Hydrochloride